1. The cytokine storm and COVID‐19;Hu;J. Med. Virol.,2021
2. National Institutes of health COVID-19 treatment guidelines;Health;Therap.Manag.Nonhospital.Adults COVID,2021
3. ADME and pharmacokinetic properties of remdesivir: its drug interaction potential;Deb;Pharmaceuticals,2021
4. Pharmacokinetic, pharmacodynamic, and drug-interaction profile of remdesivir, a SARS-CoV-2 replication inhibitor;Humeniuk;Clin. Pharmacokinet.,2021
5. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo [2, 1-F][triazin-4-Amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses;Siegel,2017